[Thrombolytic treatment of Budd-Chiari syndrome with portal venous thrombosis].
Own material of 7 patients is presented pathology: venous thrombosis involving both hepatic veins and portal system, resulting in severe impairment of liver function and portal circulation, leading up to a fatal end (if not treated). Neither surgical decompression nor liver transplantation is feasible from the technical point of view. Patients were treated with activators of fibrinolysis. In four cases the treatment was effective and resulted in recanalisation of the previously occluded veins. Early re-thrombosis was the reason of death in one case. One patient died 4 years later because of cerebral vascular thrombosis. Two others live over 5 years, symptom-free. The authors consider thrombolytic treatment as a life saving procedure in cases of hepatic and portal venous thrombosis.
Pawlak
J
J
Kliniki Chirurgii Ogólnej i Chorób Watroby Akademii Medycznej w Warszawie.
Palester-Chlebowczyk
M
M
Michałowicz
B
B
Elwertowski
M
M
Małkowski
P
P
Szczerbień
J
J
D000074:Acenocoumarol / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D006502:Budd-Chiari Syndrome / Q000188:drug therapy*; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D011169:Portal Vein; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy*
D006493:Heparin; D013300:Streptokinase; D000074:Acenocoumarol
Trombolityczne leczenie zespołu Budd-Chiari współistniejacego z zakrzepica zył trzewnych.